Troutman Sanders and Pepper Hamilton are producing a series of podcasts to discuss litigation topics that have been brought to the forefront by the COVID-19 pandemic and how businesses might be able to prepare and...more
On Aug. 13, a panel of the U.S. Court of Appeals for the Ninth Circuit issued an opinion in a securities fraud class action, Khoja v. Orexigen Therapeutics, No. 16-56069 2018 U.S. App. LEXIS 22371 (9th Cir. Aug. 13, 2018),...more
9/6/2018
/ Appeals ,
Class Action ,
Federal Rule 12(b)(6) ,
Form 10-Q ,
Form 8-K ,
Incorporation by Reference ,
Motion to Dismiss ,
Pharmaceutical Industry ,
Pleading Standards ,
PSLRA ,
Reversal ,
Securities Fraud ,
Securities Litigation
On March 5, 2014, the U.S. Supreme Court heard oral argument in Halliburton Co. v. Erica P. John Fund, Inc., No. 13-317. In this closely watched case, Halliburton has asked the Court to overrule the fraud-on-the-market...more